| ESG integration: value, growth and momentum L Kaiser Journal of Asset Management 21 (1), 32-51, 2020 | 140 | 2020 |
| Seasonality in cryptocurrencies L Kaiser Finance Research Letters 31, 2019 | 101 | 2019 |
| Cryptocurrencies: Herding and the transfer currency L Kaiser, S Stöckl Finance Research Letters 33, 101214, 2020 | 98 | 2020 |
| Risk-mitigating effect of ESG on momentum portfolios L Kaiser, J Welters The Journal of Risk Finance 20 (5), 542-555, 2019 | 87 | 2019 |
| Higher moments matter! Cross-sectional (higher) moments and the predictability of stock returns S Stöckl, L Kaiser Review of Financial Economics (forthcoming), 2020 | 10* | 2020 |
| Enhanced mean-variance portfolios: A controlled integration of quantitative predictors L Kaiser, MJ Menichetti, A Veress Journal of Portfolio Management 40 (4), 28, 2014 | 10* | 2014 |
| What drives our Beer Consumption?---In Search of Nutrition Habits and Demographic Patterns M Angerer, M Dünser, L Kaiser, G Peter, S Stöckl, A Veress Applied Economics 51 (41), 4539-4550, 2019 | 9 | 2019 |
| Environmentally (Un-) friendly portfolio construction L Kaiser, F Schaller Journal of Investment Consulting 19 (1), 43-52, 2019 | 8 | 2019 |
| Ready-to-use nanopore platform for label-free small molecule quantification: Ethanolamine as first example I Quint, J Simantzik, L Kaiser, S Laufer, D Smith, M Kohl, HP Deigner Nanomedicine: Nanotechnology, Biology and Medicine 55, 102724, 2024 | 4 | 2024 |
| Drug triggered pruritus, rash, papules, and blisters–is AGEP a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin? M Blaess, L Kaiser, O Sommerfeld, R Csuk, HP Deigner Lipids in Health and Disease 20, 1-14, 2021 | 4 | 2021 |
| Board effectiveness and firm risk L Kaiser The Journal of Impact and ESG Investing 1 (2), 68-86, 2020 | 4 | 2020 |
| Lineage-Selective Disturbance of Early Human Hematopoietic Progenitor Cell Differentiation by the Commonly Used Plasticizer Di-2-ethylhexyl Phthalate via Reactive Oxygen … L Kaiser, I Quint, R Csuk, M Jung, HP Deigner Cells 10 (10), 2703, 2021 | 3 | 2021 |
| Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype O Riester, L Kaiser, S Laufer, HP Deigner Advanced Science, 2308806, 2024 | 2 | 2024 |
| Continuous synthesis of bromoalkyl glycosides by Fischer glycosylation in a microreactor J Jung, L Kaiser, HP Deigner, MS Schmidt Journal of Flow Chemistry, 1-7, 2022 | 2 | 2022 |
| Bias and misrepresentation revisited: Perspective on major equity indices L Kaiser, M Fleisch, L Salcher Finance Research Letters 26, 223-229, 2018 | 2 | 2018 |
| Dynamic Indexes: Equity Rotation and Factor Timing L Kaiser SSRN, 2017 | 2 | 2017 |
| Categorical Evaluation of Alternative Index Weighting Schemes L Kaiser Available at SSRN 2529944, 2014 | 2 | 2014 |
| Long-Only Momentum, Currency Hedging and Transaction Costs: Implications for a Swiss Equity Investor V Devito, L Kaiser, MJ Menichetti, A Veress Available at SSRN 2338506, 2012 | 2 | 2012 |
| Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIV P Thoueille, SA Saldanha, F Schaller, E Choong, F Veuve, A Munting, ... Clinical Pharmacology & Therapeutics, 2024 | 1 | 2024 |
| A fluorescence-based competitive antibody binding assay for kynurenine, a potential biomarker of kidney transplant failure M Borgolte, I Quint, L Kaiser, R Csuk, HP Deigner Diagnostics 12 (6), 1380, 2022 | 1 | 2022 |
